CD163 and nonpapillary renal cell carcinoma: Prior research has also shown that ANLN is positively associated with CD163, a marker of M2 macrophages, suggesting that ANLN may influence M2 macrophage polarization, thereby affecting ccRCC immunotherapy responses (Gao et al., 2024).